Profile data is unavailable for this security.
About the company
Melodiol Global Health Limited, formerly Creso Pharma Limited, is an Australia-based cannabis company. The Company is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. Its cannabidiol (CBD) plant-based nutraceutical products are non-psychoactive, as they only contain trace amounts of tetrahydrocannabinol (THC). Its product is offered under various brands, including Green Goo, Southern Butter, Good Goo, Ritual, impactive and cannaQIX, among others. It cultivates and harvests cannabis plants through its subsidiary, Mernova Medicinal Inc. and supplies cannabis retail products throughout Canada. Through its wholly owned, Canada-based psychedelics subsidiary, Halucenex Life Sciences Inc., it is also focused on the development of synthetic and botanical psilocybin treatments for treatment-resistant post-traumatic stress disorder, and other mental health conditions.
- Revenue in AUD (TTM)19.60m
- Net income in AUD-35.52m
- Incorporated2015
- Employees--
- LocationMelodiol Global Health LtdSuite 5 CPC145 Stirling Highway, NedlendsPERTH 6009AustraliaAUS
- Phone+61 28067-8606
- Fax+61 89481-4950
- Websitehttps://www.cresopharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nutritional Growth Solutions Ltd | 4.47m | -4.33m | 1.00m | -- | -- | -- | -- | 0.2249 | -0.0239 | -0.0239 | 0.0232 | -0.0011 | 1.51 | 2.19 | 61.53 | -- | -145.93 | -- | -303.09 | -- | 28.22 | 42.47 | -96.95 | -152.30 | 0.1888 | -- | 1.96 | -- | 1.26 | 41.61 | 31.91 | -- | -- | -- |
| Wellfully Ltd | 1.31m | -1.34m | 1.48m | 36.00 | -- | -- | -- | 1.13 | -0.003 | -0.003 | 0.0034 | -0.0034 | 0.377 | 0.3166 | 1.57 | -- | -38.36 | -175.88 | -- | -441.84 | 48.61 | -- | -101.74 | -266.08 | 0.2159 | -- | -- | -- | -42.78 | -5.87 | 12.98 | -- | 21.75 | -- |
| Tryptamine Therapeutics Ltd | 1.21m | -4.32m | 1.93m | -- | -- | 1.78 | -- | 1.60 | -0.0162 | -0.0162 | 0.0037 | 0.0062 | 0.2368 | -- | -- | -- | -84.69 | -66.34 | -120.26 | -79.70 | -- | -- | -357.70 | -228.11 | -- | -21.62 | 0.00 | -- | -18.97 | 138.73 | 29.29 | -- | 68.45 | -- |
| BPH Global Ltd | 0.00 | -2.56m | 1.95m | 31.00 | -- | -- | -- | -- | -0.002 | -0.0025 | 0.00 | -0.0002 | 0.00 | 0.00 | -- | -- | -177.78 | -68.17 | -784.87 | -128.99 | -- | 15.29 | -- | -131.89 | 0.5587 | -4.92 | -- | -- | -99.93 | -74.08 | 19.71 | -- | 1.34 | -- |
| Hexima Ltd | 193.85k | -753.18k | 2.00m | -- | -- | 0.7877 | -- | 10.34 | -0.0045 | -0.0045 | 0.0012 | 0.0152 | 0.0558 | -- | 0.2705 | -- | -21.67 | -72.85 | -26.54 | -193.37 | -- | -- | -388.54 | -213.09 | -- | -- | 0.00 | -- | 271.52 | -19.43 | 80.85 | -- | -- | -- |
| Melodiol Global Health Ltd | 19.60m | -35.52m | 2.14m | -- | -- | -- | -- | 0.1092 | -0.2548 | -0.3762 | 0.1578 | -0.0172 | 0.6874 | 4.35 | 10.62 | -- | -124.57 | -102.92 | -387.77 | -152.32 | 15.38 | -- | -181.22 | -348.92 | 0.1594 | -6.71 | 1.73 | -- | 210.13 | 94.60 | -62.47 | -- | -46.82 | -- |
| Holista Colltech Limited | 5.95m | -4.81m | 2.79m | 3.00 | -- | -- | -- | 0.4686 | -0.0172 | -0.0172 | 0.0213 | -0.0071 | 1.35 | 2.49 | 4.70 | -- | -111.49 | -42.59 | -347.69 | -63.58 | 56.66 | 56.37 | -82.68 | -39.27 | 0.2845 | -- | -- | -- | -27.82 | -5.65 | -230.77 | -- | -37.12 | -- |
| Hydration Pharmaceuticals Co Ltd | 15.04m | -12.13m | 3.96m | -- | -- | -- | -- | 0.2636 | -0.0622 | -0.0622 | 0.0771 | -0.002 | 1.18 | 1.61 | 6.60 | -- | -94.86 | -79.98 | -143.75 | -111.57 | 53.70 | 48.73 | -80.69 | -99.53 | 1.37 | -21.48 | 1.10 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
| Bod Science Ltd | 3.32m | -7.95m | 4.26m | -- | -- | -- | -- | 1.28 | -0.0557 | -0.0557 | 0.0235 | -0.0046 | 0.7533 | 2.42 | 8.05 | -- | -180.40 | -94.62 | -465.66 | -145.77 | 69.23 | 47.08 | -239.47 | -129.48 | 0.8319 | -- | 3.71 | -- | -34.70 | 23.20 | -47.10 | -- | 8.23 | -- |
| Cambium Bio Ltd | -28.22k | -366.01k | 5.36m | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | -0.00009 | -0.0036 | -0.039 | -- | -- | -- | -50.58 | -49.44 | -- | -292.47 | -- | -- | -- | -118.34 | -- | -- | -- | -- | -- | -- | 60.86 | -- | -- | -- |
| Zelira Therapeutics Ltd | 1.62m | -36.43m | 5.56m | 8.00 | -- | -- | -- | 3.43 | -3.23 | -3.23 | 0.148 | -0.2063 | 0.0848 | 0.185 | 3.55 | -- | -193.14 | -27.71 | -243.04 | -28.81 | 82.28 | -- | -2,278.17 | -508.48 | 0.1488 | -22.80 | -- | -- | -80.95 | -0.3635 | 53.35 | -- | -- | -- |
| Invex Therapeutics Ltd | 837.95k | -6.01m | 5.71m | -- | -- | 1.08 | -- | 6.82 | -0.08 | -0.08 | 0.0112 | 0.0705 | 0.0521 | -- | 2.79 | -- | -37.38 | -- | -40.06 | -- | -- | -- | -717.76 | -- | -- | -- | 0.00 | -- | 379.22 | -- | -96.04 | -- | -- | -- |
